US Pharma MarketingThe post Lantheus Holdings’ Alzheimer’s radiodiagnostic secures FDA approval appeared first on Medical Device Network.
Lantheus Holdings’ Alzheimer’s radiodiagnostic secures FDA approval
Lantheus's radiodiagnostic is designed to identify cognitively impaired patients who have tau neurofibrillary tangle (NFT) pathology. The post Lantheus Holdings’ Alzheimer’s radiodiagnostic secures FDA approval appeared first on Medical Device Network .
Lantheus's radiodiagnostic is designed to identify cognitively impaired patients who have tau neurofibrillary tangle (NFT) pathology.
Source: Medical Device Network